The Fight for Affordable Medicine: Hospitals Take On 340B Program Changes

Neumora Gets a Big Boost: RBC Capital Markets Sees Major Upside!

A New Prescription for Prosperity: US & UK Seal Zero-Tariff Pharma Deal

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

RBC Puts the Brakes on PTC Therapeutics: Is Sephiance's Promise Already Priced In?

Europe's Quiet Ascent: How Old-World Giants Are Reshaping Global Stock Leadership

Navigating Medicare's Evolving Landscape: AARP's Crucial Insights for Your Future

The GLP-1 Revolution: A Wake-Up Call for Obesity Prevention

The Hidden Dangers of Too Much 'Good': Australia's Vitamin B6 Reckoning

Eli Lilly's Short-Term Horizon: A Look at Market Expectations

Navigating the Market: Expert Takes on Delta, Amex, Pfizer, and Harmony Gold

Beyond the Hype: Why Sanofi's CEO Says AI Won't 'Cure' Cancer

A New Era for Drug Prices: How Medicare's Negotiation Power is Reshaping Healthcare

Urogen Pharma: Unpacking the Quiet Potential of ZUSDURI in Bladder Cancer

Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults

A New Era for Biotech: Landmark Commission Calls for Radical Research Funding Overhaul

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

Forging Futures: Modi and Ramaphosa Boost Bilateral Bonds

The Shifting Sands of Pharma and Biotech: Navigating a Dynamic Job Market

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma

The Shifting Sands of Biotech M&A: Navigating a New Era with Veteran Insight

The FDA's Golden Ticket: A Moral Maze in Drug Development

Praxis Precision Medicines Stock Plummets Following Brutal Short-Seller Attack from Culper Research

The Great Divide: Will a Lifesaving HIV Drug Reach Everyone, or Just a Fortunate Few?

The Silent Threat and the Roaring Market: Sepsis's Battle for Breakthroughs

Beyond the Next Outbreak: Why Our Pandemic Preparedness Needs a Radical Rethink, From the Ground Up

The Reckoning Continues: Unpacking the Endless Aftermath of the Opioid Crisis

The Great Healthcare Pivot: Why Smart Money's Eyeing What's Next

The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients

The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

The Shifting Sands of Science: AbbVie Steps Back from Calico's Longevity Quest

The Quiet Revolution in Sleep Science: Alkermes Unveils Hope for Narcolepsy Type 2 Sufferers

The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

Divi's Laboratories: A Tale of Triumph and Tricky Valuations

The Sunflower's Secret Weapon: Kensing Unlocks a Natural Path to Heart Health in Europe